BNTC Benitec Biopharma Inc.

NASDAQ
$9.59

Benitec Biopharma Inc. (BNTC) is expected to report earnings on December 14, 2026, after the market close. The consensus earnings estimate is a loss of $0.28 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -20.8% since its last earnings release on September 14, 2026.

Benitec Biopharma Reported In-line with Estimates
Monday, September 14, 2026 · 4:00 PM ET
Earnings Date
1st Quarter, Sep 2026
Dec 14
Monday · 4:00 PM ET
Earnings Whisper
-
vs ($0.28)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $10.45

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Benitec Biopharma Inc.

Benitec Biopharma Inc. is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines.

Sector

Healthcare

Industry

Biotechnology

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.